Prediction of cancer cell line-specific synergistic drug combinations based on multi-omics data
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.We developed XDDC, an extreme gradient boosting model, to predict synergistic drug combinations for cancer therapy. This AI tool enhances drug discovery by identifying effective drug pairs, improving treatment efficacy and reducing toxicity.
Area Of Science
- Computational biology
- Pharmacogenomics
- Machine learning in drug discovery
Background
- Combination therapy offers advantages over single-drug treatments by reducing dosage and toxicity while improving efficacy.
- Predicting synergistic drug combinations is crucial for advancing cancer treatment strategies.
Purpose Of The Study
- To develop and validate an advanced machine learning model, XDDC, for predicting synergistic drug combinations against cancer cell lines.
- To leverage diverse biological and chemical data for enhanced prediction accuracy and interpretability.
Main Methods
- Utilized an extreme gradient boosting (XGBoost) algorithm to build the XDDC model.
- Integrated comprehensive drug features (chemical structures, ADRs, targets) and cell line features (gene expression, methylation, mutations, CNVs, RNAi).
- Incorporated pathway information to link drug and cell line characteristics for improved prediction.
Main Results
- The XDDC model achieved high predictive performance, with an AUC of 0.966 ± 0.002 and AUPR of 0.957 ± 0.002 on the NCI-ALMANAC dataset.
- Demonstrated superior performance compared to other machine learning methods.
- Validated predictions through literature review and experimental evidence.
Conclusions
- XDDC provides an interpretable and accurate platform for predicting synergistic drug combinations.
- The model effectively integrates multi-omics data and drug information for drug discovery.
- XDDC can significantly aid clinicians in rapidly screening effective drug combinations for specific cancer cell lines.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...